Skip to content

Internet Administered CBT for Insomnia Comorbid With Chronic Pain

Internet Administered CBT for Insomnia Comorbid With Chronic Pain Compared to Applied Relaxation Techniques - A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03425942
Acronym
SoV-studien
Enrollment
54
Registered
2018-02-08
Start date
2018-02-09
Completion date
2019-05-14
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Insomnia Due to Medical Condition

Keywords

Cognitive Behavioral Therapy, Applied Relaxation Techniques, Internet treatment

Brief summary

Cognitive behavioural therapy (CBT), that is designed to be short, concise and user friendly is compared to applied relaxation techniques as treatment for insomnia comorbid with chronic pain. Both treatments are administered via internet and participants are randomized to ether treatment arm.

Detailed description

Internet treatment with therapist support means that measurements are collected through the Internet. Participants are recruited from a specialized pain clinic for chronic pain. All patients with sleep complaints (Insomnia Severity Index \> 14) at their first visit through 2016-01-01 to 2017-07-31 are asked for participation via mail. Volunteers sign informed consent and undergo a online screening. If matching the inclusion criteria, they are contacted for a telephone interview. Subjects are assessed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criterion for insomnia disorder, M.I.N.I. (screening for psychiatric comorbidity) and the other inclusion/exclusion criteria. The treatment, that is designed to be short, concise and user friendly as it is meant to be usable as an adjunct treatment to other main interventions for chronic pain. The treatment lasts for five weeks and focuses on the most potent CBT technics for insomnia; sleep restriction and stimulus control. Randomization is conducted by university staff not otherwise involved in this study. Participants have equal chance to be allocated to ether CBT or applied relaxation techniques (active controls). The relaxation treatment lasts for the same amount of time (five weeks) and is designed to require similar weekly effort. Both groups fill in sleep diaries every week and weekly feedback is provided by master students supervised by clinical psychologists. The overall hypothesis is that CBT leads to greater symptom reduction (according to the Insomnia Severity Index) compared to applied relaxation techniques.

Interventions

BEHAVIORALInternet Cognitive Behavioral Therapy for insomnia (ICBT-i)

This intervention lasts for five weeks. The intervention is internet-based and mainly consists of the most potent CBT technics i.e. sleep restriction and stimulus control. Weekly feedback is provided by master students supervised by clinical psychologists.

BEHAVIORALInternet Applied Relaxation Techniques (IART-i)

This intervention lasts for five weeks. The intervention is internet-based and consists of different common applied relaxation exercises and treatments. Weekly feedback is provided by master students supervised by clinical psychologists.

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Participants in both the experiment condition and the active control group were told that they received one of two active treatments in a comparative study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Insomnia severity index (ISI) score \> 14 * Chronic pain

Exclusion criteria

* Shift worker or employed as a driver, operator of dangerous equipment and such * Sleep apnea, restless legs syndrome, narcolepsy, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) * Bipolar disorder, psychotic disorders, ongoing substance abuse * Having received CBT for insomnia during the latest year * Pregnancy * Severe somatic disorder (such as ongoing cancer, severe neurological condition, insufficiently treated cardiac condition) * Impaired movement to such a degree that going to bed or getting out of bed requires assistance * Not being able read or wright in Swedish * Not having an internet-connected computer, cellular phone or tablet

Design outcomes

Primary

MeasureTime frameDescription
Insomnia Severity Index (ISI)Change from baseline insomnia severity (ISI) at 6 monthsMeasures degree of insomnia. Range 0-28 where a higher value indicates worse sleep.

Secondary

MeasureTime frameDescription
Patient Health Questionnaire (PHQ-9)Change from baseline health (PHQ-9) at 6 monthsMeasures depressive symptoms. Range 0-27, where a higher value indicates more depressive symptoms.
Generalised Anxiety Disorder 7-item scale (GAD-7)Change from baseline anxiety (GAD-7) at 6 monthsMeasures anxiety symptoms. Range 0-21 where a higher value indicates more anxiety.
Pain intensity (NRS)Change from baseline pain intensity (NRS) at 6 monthsEleven stepped numeric rating scale (NRS) for average pain last seven days. Higher values indicate higher pain intensity.
Pain Disability Index (PDI)Change from baseline disability (PDI) at 6 monthsQuantifying pain related disability. Range 0-70 where a higher value indicates more disability.
Sleep diaryDaily during treatment (five weeks).Basis for sleep latency, total sleep time, wake time after sleep onset and sleep efficiency.
The Karolinska Sleepiness Scale (KSS)Change from baseline sleepiness (KSS) at 5 weeksMeasures sleepiness on a single item numeric rating scale. Range 1-9, where a higher value indicates more sleepiness.

Other

MeasureTime frameDescription
Patient Health Questionnaire (PHQ-4)Change from baseline health (PHQ-4) at 5 weeksMeasures depressive symptoms and anxiety. Range 0-12 where a higher value indicates more depressive or anxiety symptoms.
Pain spreading (PS)Change from baseline pain spreading (PS) at 6 monthsNumber of anatomical regions with pain out of 36 anatomical areas.
Negative Effects Questionnaire (NEQ)at 5 weeks and at 6 monthsMonitoring and Reporting Adverse and Unwanted Events (32 items). Range 0-128 where a higher value indicates more adverse events.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026